For Example, in triple damaging breast cancer (TNBC),twenty five and in hepatocellular carcinoma,26 DNA methylation profiles have served towards the identification of distinctive subgroups with clinical relevance. Epigenetic ways have also assisted to the event of prognostic exams to evaluate the sensitivity of cancer cells to certain medicine.27 A https://directivepublications.org/world-journal-of-clinical-cancer-research/